The long-acting, injectable therapy was 66% more effective than daily oral tablets at preventing HIV
Phase I clinical testing scheduled to begin mid-July
The drug is the only PARP inhibitor approved in this disease
GSK’s ViiV tackles HIV stigma with new campaign starring popular Welsh rugby player beth.bulik Tue, 07/07/2020 – 17:53
Roche hooks up with U.K. pharmacy Boots to promote mySugr diabetes management app beth.bulik Tue, 07/07/2020 – 15:28
Over the past few decades, medical technology seen various advances in terms of the scope and efficiency of […]
We agree with McKee and colleagues that any delay in finding solutions to the challenges of covid-19 must […]
The UK government must immediately issue an apology “on behalf of the healthcare system” to people affected by […]
Updated Date: Tue, 30 Jun 2020 00:00:00 EDT